TLPPF - Telix Pharmaceuticals Limited reports Q4 results
- Telix Pharmaceuticals Limited press release ( OTCPK:TLPPF ): Q4 Revenue of $78.2M (+41.4% Q/Q).
- Net operating cash flow improved by $6.9M over the prior quarter to a $1.6M inflow for the quarter.
- Cash receipts from customers were $72.2M, up 62% from $44.5M in the prior quarter.
For further details see:
Telix Pharmaceuticals Limited reports Q4 results